Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 18, 2025 08:15 ET | Source: Curative Biotechnology, Inc. 

Curative Biotechnology, Inc. Announces Letter to Shareholders

Strategic Update and New Path to Value Creation Palm Beach Gardens, FL, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a...
November 18, 2025 07:00 ET | Source: INNEOVA Holdings Limited

INNEOVA Holdings’ CEO Issues Letter to Shareholders

Charting INEO’s Next Chapter: Powering a Sustainable and Intelligent Future SINGAPORE, Nov. 18, 2025 (GLOBE NEWSWIRE) -- INNEOVA Holdings Limited (“INNEOVA Holdings” or the “Company”) (Nasdaq:...
November 17, 2025 10:30 ET | Source: Global AI, Inc.

Global AI CEO Issues Letter to Shareholders with Updates on Expansion, Platform Momentum, and Uplisting Plans

New York, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Global AI Inc. (OTC: GLAI), a leader in enterprise artificial intelligence (AI) and agentic AI products and solutions, today provided a letter to...
August 14, 2025 08:00 ET | Source: PharmaTher Holdings Ltd.

PharmaTher Founder and CEO Issues Letter to Shareholders following the FDA Approval of Ketamine (KETARx™)

TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company focused on unlocking the...
April 16, 2025 09:00 ET | Source: NeuroOne Medical Technologies Corporation

NeuroOne® Issues Letter to Shareholders

Company Now Fully Funded Through at least Fiscal 2026; Company Confirms No Material Impact from Global Tariffs EDEN PRAIRIE, Minn., April 16, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies...
January 22, 2025 09:00 ET | Source: NEXGEL, INC.

NEXGEL Issues Letter to Shareholders and Provides Guidance for 2024 and 2025

Management expects 2024 fourth quarter revenue of approximately $3.0 million and full year 2024 of approximately $8.6 million, representing growth year-over-year of over 100% for the third consecutive...
December 02, 2024 08:00 ET | Source: Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B

Transaction Creates Opportunity to Share in Potential Upside of Pharma Two B’s Late-Clinical Stage Candidate to Treat Parkinson’s Disease Hepion’s Board Unanimously Recommends Shareholders Approve...
October 28, 2024 09:00 ET | Source: Cavitation Technologies, Inc

Cavitation Technologies, Inc. Provides Corporate Update and Letter to Shareholders, Goals for Fiscal Year 2025, and Recent Transaction With Desmet Belgium, SA

CHATSWORTH, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Cavitation Technologies, Inc. ("CTi" or the "Company") (OTCQB: CVAT), a leading ESG company designing and manufacturing innovative flow-through...
October 16, 2024 08:45 ET | Source: BioElectronics Corporation

BioElectronics Corporation's Chairman Updates Investors

Outlines Sales Activities, Clinical Trials, and a Potential Legal Action Against MundiPharma FREDERICK, Md., Oct. 16, 2024 (GLOBE NEWSWIRE) -- BioElectronics Corporation (https://www.bielcorp.com/...
January 09, 2024 08:10 ET | Source: Foresight Autonomous Holdings Ltd.

Foresight CEO Letter to Shareholders

Ness Ziona, Israel, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX). Dear Shareholders, Looking back at the dynamic events of the past year, I am...